Fatty acid, dyslipidaemia and insulin resistance - Preface

Fatty acid, dyslipidaemia and insulin resistance - Preface

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Karpe, F, Coppack, S
Μορφή:	Journal article
Έκδοση:	2002

Παρόμοια τεκμήρια

Journal of the Royal Society of Medicine: Preface
ανά: Karpe, F, κ.ά.
Έκδοση: (2002)

Fatty acids, obesity, and insulin resistance: time for a reevaluation.
ανά: Karpe, F, κ.ά.
Έκδοση: (2011)

Metabolic Syndrome: Insulin Resistance, Obesity, Diabetes Mellitus, Hypertension, Physical Activity and Genetic Factors
ανά: Coppack, S, κ.ά.
Έκδοση: (2008)

Adipose tissue fatty acid metabolism in insulin-resistant men.
ανά: Bickerton, A, κ.ά.
Έκδοση: (2008)

Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
ανά: Watts, G, κ.ά.
Έκδοση: (2011)

Interaction Among Sex, Aging, and Epigenetic Processes Concerning Visceral Fat, Insulin Resistance, and Dyslipidaemia
ανά: Ana Arpón, κ.ά.
Έκδοση: (2019-07-01)

Oscillations of fatty acid and glycerol release from human subcutaneous adipose tissue in vivo.
ανά: Karpe, F, κ.ά.
Έκδοση: (2005)

Insulin plant (Costus pictus) extract improves insulin sensitivity and ameliorates atherogenic dyslipidaemia in fructose induced insulin resistant rats: Molecular mechanism
ανά: S. Ashwini, κ.ά.
Έκδοση: (2015-08-01)

Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased.
ανά: Frayn, K, κ.ά.
Έκδοση: (2008)

Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
ανά: Watts, G, κ.ά.
Έκδοση: (2011)

Insulin resistance reduces the contribution of systemic plasma non-esterified fatty acids into very low-density lipoprotein triacylglycerol
ανά: Hodson, L, κ.ά.
Έκδοση: (2007)

Insulin resistance, adipose tissue and coronary heart disease.
ανά: Frayn, K, κ.ά.
Έκδοση: (1992)

Secondary dyslipidaemia
ανά: D.J. Blom
Έκδοση: (2011-07-01)

Diabetic dyslipidaemia
ανά: Subashini C. Thambiah, κ.ά.
Έκδοση: (2021-08-01)

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
ανά: Beysen, C, κ.ά.
Έκδοση: (2002)

The Effect of Omega-3 Fatty Acids on Insulin Resistance
ανά: Susmita Sinha, κ.ά.
Έκδοση: (2023-06-01)

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance[S]
ανά: Myoung Sook Han, κ.ά.
Έκδοση: (2011-06-01)

Association of nonalcoholic fatty liver with carotid intima-media thickness in patients with dyslipidaemia
ανά: Hamid Dehdashti Shahroukh, κ.ά.
Έκδοση: (2018-09-01)

Dyslipidaemia in endocrine disorders
ανά: Kalyani Sridharan, κ.ά.
Έκδοση: (2024-03-01)

Treatment of Dyslipidaemia in Children
ανά: Riccardo Fiorentino, κ.ά.
Έκδοση: (2021-08-01)

Dyslipidaemia in Sri Lanka
ανά: Anne Thushara Matthias, κ.ά.
Έκδοση: (2022-01-01)

Advances on the treatment of Dyslipidaemias
ανά: Eleni Bilianou
Έκδοση: (2017-01-01)

Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia
ανά: Benjamin eBarzel, κ.ά.
Έκδοση: (2014-12-01)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
ανά: S S Iyengar, κ.ά.
Έκδοση: (2020-01-01)

Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure
ανά: Albert Kwok, κ.ά.
Έκδοση: (2020-10-01)

Insulin resistance by adiponectin deficiency: is the action in skeletal muscle?
ανά: Karpe, F
Έκδοση: (2013)

Adipose tissue fatty acid metabolism in insulin-resistant men (Diabetologia DOI: 10.1007/s00125-008-1040-x)
ανά: Bickerton, A, κ.ά.
Έκδοση: (2008)

New concepts in the management of dyslipidaemia
ανά: Baris Gencer, κ.ά.
Έκδοση: (2016-11-01)

Dyslipidaemia in elderly and stroke patients
ανά: Dhiman Kahali
Έκδοση: (2024-03-01)

Managing dyslipidaemia in young adults
ανά: Jamshed J. Dalal, κ.ά.
Έκδοση: (2024-03-01)

Role of statins in the management of dyslipidaemia
ανά: Saumitra Ray
Έκδοση: (2024-03-01)

The changing paradigm of dyslipidaemia management
ανά: Ruvan Ekanayaka
Έκδοση: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
ανά: Iciar Martín-Timón, κ.ά.
Έκδοση: (2018-11-01)

Adipose tissue function in the insulin-resistance syndrome.
ανά: Karpe, F, κ.ά.
Έκδοση: (2005)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
ανά: Leila Azadbakht, κ.ά.
Έκδοση: (2011-01-01)

Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men.
ανά: Boquist, S, κ.ά.
Έκδοση: (2000)

Hypertension and Dyslipidaemia in Argentina: Patient Journey Stages
ανά: Sadler AE, κ.ά.
Έκδοση: (2022-10-01)

Seasonal variation lipid levels in the patients with dyslipidaemia
ανά: I V Radysh, κ.ά.
Έκδοση: (2009-12-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
ανά: Anandita Agarwala, κ.ά.
Έκδοση: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
ανά: Giuseppe Danilo Norata
Έκδοση: (2012-01-01)